| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9c03c467ca287be13e5d7fc44c8f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2288d855b6b93119a9e012393ef00730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbbe8ff1a8c7b5203dd61e7cfe488d79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c3f6266850a4b58f0eea92ee74cda96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0fb57a2149c56aeb22223889490c8c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a739eeff12f19a6af1a4c59b1d4239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf65720f03e5e08f945d51f530f88718 |
| publicationDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014100162-A1 |
| titleOfInvention |
Prevention of kidney injury disease |
| abstract |
The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease. |
| priorityDate |
2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |